RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Optimal Regulation Performance of MIMO Networked Time-delay Systems With Limited Bandwidth and Interference Signals

        Qianhao Li,Qingsheng Yang,Xisheng Zhan,Jie Wu 제어·로봇·시스템학회 2024 International Journal of Control, Automation, and Vol.22 No.2

        In this paper, we investigate the optimal regulation performance of networked time delay systems with limited bandwidth and interference signals. Communication networks are primarily influenced by parameters including bandwidth, packet dropouts, coding and decoding, interference signals, and channel noise. For a given system, non-minimum phase zeros, unstable poles, and time delay are considered. The corresponding regulation performance expressions are derived using coprime decomposition, spectral decomposition techniques, and norm correlation theory in the frequency domain. Results indicate that regulation performance is dependent on the location and direction of non-minimum phase zeros and unstable poles of a given system, as well as the internal time delay of the controlled plant. In addition, network communication parameters such as bandwidth, channel noise, packet dropouts, and external interference signals influence the performance of the regulation. Finally, simulation examples are provided to demonstrate the theory’s validity.

      • SCOPUSKCI등재

        Efficacy of Different Number of XELOX or SOX Chemotherapy Cycles After D<sub>2</sub> Resection for Stage III Gastric Cancer

        Yu, Yuanyuan,Zhang, Zicheng,Meng, Qianhao,Wang, Ke,Li, Qingwei,Ma, Yue,Yao, Yuanfei,Sun, Jie,Wang, Guangyu The Korean Gastric Cancer Association 2022 Journal of gastric cancer Vol.22 No.2

        Purpose: We aimed to explore whether the prognosis of patients treated with capecitabine and oxaliplatin (XELOX) or S-1 and oxaliplatin (SOX) regimens who received fewer cycles of chemotherapy after D2 radical resection for gastric cancer (GC) would be non-inferior to that of patients who received the standard number of cycles of chemotherapy. Materials and Methods: Data on patients who received XELOX or SOX chemotherapy after undergoing D2 radical resection at Harbin Medical University Cancer Hospital between January 2011 and May 2016 were collected. Results: In patients who received 4, 6, and 8 cycles of chemotherapy, the 5-year overall survival (OS) rates were 59.4%, 64.8%, and 62.7%, respectively. Compared to patients who received 4 cycles of chemotherapy, those who received 6 cycles (hazard ratio [HR], 0.882; 95% confidence interval [CI], 0.599-1.299; P=0.52) or 8 cycles (HR, 0.882; 95% CI, 0.533-1.458; P=0.62) of chemotherapy did not exhibit significantly prolonged OS. The 3-year disease-free survival (DFS) rate of patients who received 4, 6, and 8 cycles of chemotherapy was 62.1%, 67.2%, and 60.8%, respectively. Compared to patients who received 4 cycles of chemotherapy, those who received 6 cycles (HR, 0.835; 95% CI, 0.572-1.221; P=0.35) or 8 cycles (HR, 0.972; 95% CI, 0.606-1.558; P=0.91) of chemotherapy did not show significantly prolonged DFS. However, the 3-year DFS and 5-year OS rates of patients who received 6 cycles of chemotherapy appeared to be superior to those of patients who received 4 and 8 cycles of chemotherapy. Conclusions: For patients with stage III GC, 4 to 6 cycles of XELOX or SOX chemotherapy may be a favorable option. This study provides a rationale for further randomized clinical trials.

      • KCI등재

        Development of supporting platform for the fine flow characteristics of reactor core

        Qian Hao,Chen Guangliang,Li Lei,Zhang Lixuan,Yin Xinli,Zhang Hanqi,Su Shaomin 한국원자력학회 2024 Nuclear Engineering and Technology Vol.56 No.5

        This study presents the Supporting platform for reactor fine flow characteristics calculation and analysis (Cilian platform), a user-friendly tool that supports the analysis and optimization of pressurized water reactor (PWR) cores with mixing vanes using computational fluid dynamics (CFD) computing. The Cilian platform allows for easy creation and optimization of PWR’s main CFD calculation schemes and autonomously manages CFD calculation and analysis of PWR cores, reducing the need for human and computational resources. The platform’s key features enable efficient simulation, rapid solution design, automatic calculation of core scheme options, and streamlined data extraction and processing techniques. The Cilian platform’s capability to call external CFD software reduces the development time and cost while improving the accuracy and reliability of the results. In conclusion, the Cilian platform exemplifies an innovative solution for efficient computational fluid dynamics analysis of pressurized water reactor (PWR) cores. It holds great promise for driving advancements in nuclear power technology, enhancing the safety, efficiency, and cost-effectiveness of nuclear reactors. The platform adopts a modular design methodology, enabling the swift and accurate computation and analysis of diverse flow regions within core components. This design approach facilitates the seamless integration of multiple computational modules across various reactor types, providing a high degree of flexibility and reusability

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼